Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy

Epilepsy Research

Volumn 33, Issue 1, 1999, Pages 57-65

  May, Theodor ^a   Jürgens, Uwe ^a   Rambeck, Bernhard ^a   Schnabel, Ralf ^b,c  

^a Epilepsy Research Foundation   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c EPILEPSY CENTER BETHEL   (Germany)

Author keywords

Carbamazepine; Carbamazepine 10,11 epoxide; Epilepsy; Phenobarbital; Phenytoin; Postmortem drug levels; Premortem drug levels; Sudden unexplained death; Toxicology

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; PHENOBARBITAL; PHENYTOIN;

ADULT; AGED; ARTICLE; AUTOPSY; CAUSE OF DEATH; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; INSTITUTIONALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHENOBARBITAL; PHENYTOIN; POSTMORTEM CHANGES; TIME FACTORS;

EID: 0344699377     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00071-0     Document Type: Article

References (36)

1. Boucher, B.A., Rodman, J.H., Fabian, T.C., Cupit, G.C., Ludden, T.M., West, M.E., Ray, M.W., 1987. Disposition of phenytoin in critically ill trauma patients. Clin. Pharmacol. 6, 881-887.
2. Boucher, B.A., Rodman, J.H., Jaresko, G.S., Rasmussen, N.S., Watridge, C.B., Fabian, T.C., 1988. Phenytoin pharmacokinetics in critically ill trauma patients. Clin. Pharmacol. Ther. 44, 675-683.
3. Brown, S.W., 1992. Sudden death and epilepsy. Seizure 1, 71-73.
4. Coyle, H.P., Baker-Brian, N., Brown, S.W., 1994. Coroners' autopsy reporting of sudden unexplained death in epilepsy (SUDEP) in the UK. Seizure 3, 247-254.
5. Dijkhuis, I., Vervloet, E., 1974. Rapid determination of the antiepileptic drug di-n-propylacetic acid in serum. Pharm. Weekbl. 109, 42-45.
6. Dreifuss, F.E., 1995. Other antiepileptic drugs. Bromides. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs, 4th ed. Raven, New York, pp. 949-951.
7. Earnest, M.P., Thomas, G.E., Eden, R.A., Hossack, K.F., 1992. The sudden unexplained death syndrome in epilepsy: demographic, clinical and postmortem features. Epilepsia 33, 310-316.
8. Hirsch, C.S., Martin, D.L., 1971. Unexpected death in young epileptics. Neurol. Minneap. 21, 682-690.
9. Hooper, W.D., Bochner, F., Eadie, M.J., Tyrer, J.H., 1973. Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease. Clin. Pharmacol. Ther. 15, 276-282.
10. Johnston, S.C., Horn, J.K., Valente, J., Simon, R.P., 1995. The role of hypoventilation in a sheep model of epileptic sudden death. Ann. Neurol. 37, 531-537.
11. Jürgens, U., 1987. Simultaneous determination of Zonisamide and nine other anti-epileptic drugs and metabolites in serum. A comparison of microbore and conventional high-performance liquid chromatography. J. Chromatogr. 385, 233-240.
12. Jürgens, U., May, T., Hillenkötter, K., Rambeck, B., 1984. Systematic comparison of three basic methods of sample pretreatment for high-performance liquid chromatographic analysis of antiepileptic drugs using gas chromatography as a reference method. Ther. Drug Monit. 6, 334-343.
13. Lathers, C.M., Schraeder, P.L. (Eds.), 1990. Epilepsy and Sudden Death. Marcel Dekker, New York.
14. Lathers, C.M., Schraeder, P.L., 1995. Experience-based teaching of therapeutics and clinical pharmacology of antiepileptic drugs. Sudden unexplained death in epilepsy: do antiepileptic drugs have a role? Clin. Pharmacol. 35, 573-587.
15. Lathers, C.M., Weiner, F.L., Schraeder, P.L., 1983. Synchronisation of cardiac autonomie neural discharge with epileptogenic activity: the lockstep phenomenon. Circ. Res. 31, 630A.
16. Leestma, J.E., 1990. Sudden unexpected death associated with seizures: a pathological review. In: Lathers, C.M., Schraeder, P.L. (Eds.), Epilepsy and Sudden Death. Marcel Dekker, New York, pp. 61-88.
17. Leestma, J.E., Kalelkar, M.B., Teas, S.S., Jay, G.W., Hughes, J.R., 1984. Sudden unexpected death associated with seizures: analysis of 66 cases. Epilepsia 25, 84-88.
18. Lown, B., 1980. Higher nervous activity and sudden cardiac death. Bull. Mem. Acad. R. Med. Belg. 135, 487-505.
19. Lund, A., Gormsen, H., 1985. The role of antiepileptics in sudden death in epilepsy. Acta Neurol. Scand. 72, 444-446.
20. May, T., Rambeck, B., 1985. Serum concentrations of valproic acid: influence of dose and comedication. Ther. Drug Monit. 7, 387-390.
21. May, T.W., Korn-Merker, E., Rambeck, B., Boenigk, H.E., 1994. Pharmacokinetics of sulthiame in epileptic patients. Ther. Drug Monit. 16, 251-257.
22. Ohlmacher, A.P., 1910. Acute pulmonary edema as a terminal event in certain forms of epilepsy. Am. J. Med. Sci. 139, 417-422.
23. Oppenheimer, S., 1990. Cardiac dysfunction during seizures and the sudden epileptic death syndrome. J. R. Soc. Med. 83, 134-137.
24. Perucca, E., 1980. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring. Ther. Drug Monit. 2, 331-344.
25. Rambeck, B., Schnabel, R., May, T., Jürgens, U., Villagrán, R., 1990. Postmortem serum protein binding and brain concentrations of antiepileptic drugs in autoptic specimens from 45 epileptic patients. Ther. Drug Monit. 12, 533-540.
26. Rambeck, B., Schnabel, R., May, T., Jürgens, U., Villagrán, R., 1992. Postmortem concentrations of phenytoin in different regions of the brain and in the serum: analysis of autoptic specimens from 24 epileptic patients. Ther. Drug Monit. 14, 27-35.
27. Rambeck, B., Schnabel, R., May, T., Jürgens, U., Villagrán, R., 1993. Postmortem concentrations of phenobarbital, carbamazepine, and its metabolite carbamazepine-10,11-epoxide in different regions of the brain and in the serum: analysis of autoptic specimens from 51 epileptic patients. Ther. Drug Monit. 15, 91-98.
28. Reidenberg, M.M., Odar-Cederlöf, I., von Bahr, C., Borgå, O., Sjöqvist, F., 1971. Protein binding of diphenylhydantoin and desmethylimipamine in plasma from patients with poor renal function. New Engl. J. Med. 285, 264-267.
29. Schnabel, R., 1986. Morphologische Aspekte bei cerebralen Anfallsleiden und ein Beitrag zum plötzlichen, unerwarteten, unerklärbaren Tod. Beitr. Z. Gerichtl. Med. 44, 159-177.
30. Schnabel, R., Rambeck, B., May, T.W., Jürgens, U., Lahl, R., Villagrán, R., 1996. Lack of effect of histological lesions on the phenytoin and phenobarbital concentrations in the brain cortex of epileptic patients. J. Neurol. Sci. 133 (1995) 177-182, Erratum. J. Neurol. Sci. 144 (1995), 231-232.
31. Schraeder, P.L., Lathers, C.M., 1989. Paroxysmal cardiovascular dysfunction and epileptogenic activity. Epilepsy Res. 3, 55-62.
32. Schwender, L.A., Troncoso, J.C., 1986. Evaluation of sudden death in epilepsy. Am. J. Forensic Med. Pathol. 7, 283-287.
33. Terrence, C.F., Wisotzkey, H.M., Perper, J.A., 1975. Unexpected unexplained death in epileptic patients. Neurology 25, 594-598.
34. Tomson, T., Sköld, A.-C., Holmgen, P., Nilsson, L., Danielsson, B., 1998. Postmortem changes in blood concentrations of phenytoin and carbamazepine: an experimental study. Ther. Drug Monit. 20, 309-312.
35. Uges, D.R.A., 1997. Orientierende Angaben zu therapeutischen und toxischen Konzentrationen von Arzneimitteln und Giften in Blut, Serum oder Urin. In: Mitteilung XV der Senatskommission für klinisch-toxikologische Analytik, Deutsche Forschungsgemeinschaft. VCH, Weinheim, pp. 83-106.
36. Wannamaker, B.B., 1990. A perspective on death of persons with epilepsy. In: Lathers C.M., Schraeder, P.L. (Eds.), Epilepsy and Sudden Death. Marcel Dekker, New York, pp. 27-37.